With the Jaypee acquisition, the Suraksha group, which made lenders an offer of Rs 7,736 crore, will be able to expand its footprint in north India after making inroads in Mumbai's real estate market over the past year. Sudhir Valia, the promoter, was a co-founder and executive director of India's biggest pharmaceutical firm, Sun Pharmaceuticals, and is a close relative of Dilip Shanghvi.
The government on Saturday made its prior approval mandatory for foreign investments from countries that share land border with India to curb 'opportunistic takeovers' of domestic firms following the COVID-19 pandemic, a move which will restrict Foreign Direct Investment from China.
The agency is also preparing to analyse the details of assets of the Kochhars and others so that they can be provisionally attached under the Prevention of Money Laundering Act
In 2008, the 13 companies on the list accounted for 34 per cent of the overall m-cap.
The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent.
Top 100 billionaires see their wealth rise 10%; top 20 account for half of total wealth of top 100.
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
'The failures of private businessmen have set back the process of market-oriented reform, though that is the only way forward,' argues T N Ninan.
As the death toll in the country from coronavirus jumped by a record 445 to 13,699, the Centre maintained that the number of infections per lakh population was among the lowest in the world. The new cases surged by over 10,000 for the 11th day in a row and rose by 14,821 to take the total to 4,25,282, according to health ministry data.
At present, there is no direct air connectivity between India and Myanmar.
One of the reasons for the failure, say industry experts and financial analysts, is that Emami strayed too far from its core with sanitary napkins.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
As per the law, political parties are to declare a list of their political donors. However, as per the latest report, political parties continue to enjoy donations without providing their names or addresses, reports Vicky Nanjappa
'The success of the country's economic policies is affirmed by receipt of FDI of $15 billion last year, the highest in the Asia-Pacific after China and India, and well ahead of Indonesia, Australia, Singapore, Malaysia and Thailand,' notes Ambassador Talmiz Ahmad.
Asia's falling stocks have triggered an exodus of funds from the region.
Rediff readers tell us what their first salary was and what it meant to them at the time.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
Financials were the top gainers lead by private lenders ICICI Bank and HDFC Bank
IndiGo Airlines signs $2.6-billion leasing and financing MoU with Industrial and Commercial Bank of China.
The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.
Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.
Prime Minister Narendra Modi's three-day visit to Britain has seen India and the UK agreeing on Rs 90,000 crore deals.
"We will be guided by our national interest," he said.
The Zandu business grew rapidly, and we became debt-free within two years of the deal.
It is domestic policy distortions and inaction to correct them that lie behind the large CADs.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.
The S&P BSE Sensex ended 80 points up at 23,789 while the Nifty50 closed at 7,235, up 24 points.
India was the flavour of the year, at least in the FMCG sector, as multinationals hiked stakes in their subsidiaries lured by long term potential of the country, while homegrown executives made their way to top hierarchy of global firms in 2013.
Few top honchos of India Inc did very well in 2014.
The 30-share Sensex ended down 604 points at 28,845 and the 50-share Nifty ended down 181 points at 8,757. The Bank Nifty ended down 602 points at 19,146.
Nifty50 surged 87 points to end at 8,157, highest closing levels since Oct 29, 2015.
Think beyond engineering and medicine.
Happy at the clear mandate given by voters to the BJP-led NDA, India Inc on Friday exuded confidence that Narendra Modi will initiate bold and decisive policy reforms to promote economic growth.
Markets recorded their biggest single-day fall since August 1 amid growth concerns in the euro zone.
Rather than focussing on manufacturing, Indian companies need to concentrate on conceiving, designing and branding products.
'A law firm checked credentials of Karan Ajit Judge and Nouam'
The group's much-touted acquisitions in recent years follow a series of disappointments in joint ventures.
Admittedly, EVMs too have a UID number and any convergence of data can make the secret ballot system a party of history, warns Dr Gopal Krishna in the 5th part of his series against Aadhaar.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances